These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15281338)
1. Molecular pathology of the pituitary. Development and functional differentiation of pituitary adenomas. Osamura RY; Egashira N; Miyai S; Yamazaki M; Takekoshi S; Sanno N; Teramoto A Front Horm Res; 2004; 32():20-33. PubMed ID: 15281338 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of PIT-1 protein in pituitary glands of human GRF transgenic mice: its relationship with hormonal expressions. Osamura RY; Oda K; Utsunomiya H; Inada K; Umemura S; Shibuya M; Katakami H; Voss JW; Mayo KE; Rosenfeld MG Endocr J; 1993 Feb; 40(1):133-9. PubMed ID: 7951487 [TBL] [Abstract][Full Text] [Related]
4. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758 [TBL] [Abstract][Full Text] [Related]
5. Expression of FOXL2 in human normal pituitaries and pituitary adenomas. Egashira N; Takekoshi S; Takei M; Teramoto A; Osamura RY Mod Pathol; 2011 Jun; 24(6):765-73. PubMed ID: 21478824 [TBL] [Abstract][Full Text] [Related]
6. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas. Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804 [TBL] [Abstract][Full Text] [Related]
7. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues. Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449 [TBL] [Abstract][Full Text] [Related]
8. Cytochemical and molecular biological aspects of the pituitary and pituitary adenomas--cell differentiation and transcription factors. Sanno N; Tahara S; Kurotani R; Matsuno A; Teramoto A; Osamura RY Prog Histochem Cytochem; 2001; 36(4):263-99. PubMed ID: 11822191 [TBL] [Abstract][Full Text] [Related]
10. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line. Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148 [TBL] [Abstract][Full Text] [Related]
11. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method. Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563 [TBL] [Abstract][Full Text] [Related]
12. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage. Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102 [TBL] [Abstract][Full Text] [Related]
13. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product. Sanno N; Teramoto A; Matsuno A; Osamura RY Arch Pathol Lab Med; 1996 Jan; 120(1):73-7. PubMed ID: 8554449 [TBL] [Abstract][Full Text] [Related]
14. Contributions of immunohistochemistry and in situ hybridization to the functional analysis of pituitary adenomas. Osamura RY; Tahara S; Kurotani R; Sanno N; Matsuno A; Teramoto A J Histochem Cytochem; 2000 Apr; 48(4):445-58. PubMed ID: 10727285 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical characterisation of human pituitary adenomas. Dorn A; Nyström S; Müller M; Rinne A; Kyllönen A; Bernstein HG; Schwesinger G; Leppäluoto J Zentralbl Neurochir; 1985; 46(3):188-94. PubMed ID: 3911665 [TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839 [TBL] [Abstract][Full Text] [Related]
18. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Oyama K; Sanno N; Teramoto A; Osamura RY Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786 [TBL] [Abstract][Full Text] [Related]
19. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas. Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039 [TBL] [Abstract][Full Text] [Related]
20. Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution. Osamura RY; Egashira N; Kajiya H; Takei M; Tobita M; Miyakoshi T; Inomoto C; Takekoshi S; Teramoto A Acta Histochem Cytochem; 2009 Aug; 42(4):95-104. PubMed ID: 19759870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]